§ Independent data · no vendor input

The Peptigrity Purity Index

The Peptigrity Purity Index is a recency-weighted composite of third-party HPLC purity results — currently 99.49 across 9,016 published tests of 61 compounds.

Updated automatically · last update

99.49
Composite purity index
±0.00 quarter over quarter
9,016 tests · 61 compounds · 26 labs
2022 Q4 → 2026 Q3
9,023
Tests analysed
61
Compounds covered
0.32%
Purity-fail rate (<95%)
26
Contributing labs

Composite by quarter

Back-computed from each certificate's test date — the full history since 2019-11-10.

98.699.299.82022Q42023Q22023Q42024Q22024Q42025Q22025Q42026Q22026Q3

Index by compound

61 of 64 tested compounds meet the 5-test publication threshold. Sub-threshold compounds show an em dash — never an estimate.

CompoundIndex90-dayTestsLabs
Tirzepatide99.75 0.0181321
Vilon99.75 0.03158
PT-14199.70±0.0021021
Melanotan I (MT-1)99.68 0.0210716
Vesugen99.68 0.10179
Retatrutide99.67 0.011,01024
Semaglutide99.67±0.0038221
Ipamorelin99.67 0.0128221
SS-31 (Elamipretide)99.67 0.0217114
Testagen99.67 0.07168
GHK-Cu99.66 0.0144823
SELANK99.64 0.0224122
Melanotan II (MT-2)99.63 0.0121820
Cagrilintide99.63 0.0120619
N-Acetyl Semax Amidate99.63 0.02249
Adamax (Davunetide/NAP)99.63 0.09126
Cartalax99.61 0.033810
KPV99.59 0.0118620
Survodutide99.59 0.01339
FOXO4-DRI99.58 0.044211
5-Amino-1MQ99.56 0.0512118
Glutathione99.56 0.038714
Mazdutide99.56 0.01288
Aicar99.56 0.04116
Pinealon99.53 0.035610
PNC-2799.53 0.07137
P21 (P021)99.52 0.0663
Gonadorelin99.51 0.06105
Thymosin-Alpha 1 (A1)99.50±0.0019717
CJC-1295 without DAC99.50 0.0118122
LL-3799.49 0.084915
Kisspeptin99.47 0.0413917
Prostamax99.47 0.1895
SEMAX99.45 0.0123521
Cardiogen99.45 0.14136
MOTS-C 99.43 0.0143723
Pancragen99.43 0.0274
Tesamorelin99.42 0.0340824
VIP (Vasoactive Intestinal Peptide)99.42 0.025313
TB-50099.40 0.0232422
EPITHALON99.40±0.0021418
Crystagen99.4053
PEG MGF99.39 0.022111
BPC-15799.38 0.0253923
Sermorelin99.35±0.0018416
GHRP-699.35 0.044010
SNAP-899.34 0.057213
DSIP (Delta Sleep-inducing Peptide)99.25 0.0218920
CJC-1295 with DAC99.20 0.069714
GHRP-299.18 0.093110
AOD-960499.16 0.3811816
Hexarelin99.04 0.09238
HGH Fragment 176–19199.00 0.135412
NAD+98.98 0.0226419
Oxytocin98.92 0.324713
Follistatin98.80 0.7676
ARA-29098.68 0.467512
THYMALIN98.66 0.764313
IGF-1 LR398.54 0.0111317
Ovagen98.11 0.5765
AHK-Cu95.35 4.23199
Adipotide42
IGF-1 DES21
EPO (Erythropoietin)11

Movers

What fails, and how

0.32%

of 10,342 published tests fall below 95% purity (33 tests). The research-grade bar is 95%; strong results clear 98%.

7.50%

of 10,124 tests with a measured net-content figure came in underdosed — below 95% of the labelled amount (759 tests).

Identity confirmation by mass spectrometry is not captured as structured data, so a “wrong compound” rate is deliberately not reported rather than estimated.

What the Peptigrity Purity Index measures

The index measures the recency-weighted average purity of research peptides that have been independently tested by third-party laboratories — currently 99.49 across 9,016 published HPLC results. It reflects the samples that were tested, not the market as a whole.

How the index is calculated

Each compound's index is the mean of its published HPLC purity results, weighted by recency: a test within 90 days counts at full weight, one within a year at 0.6, and older tests at 0.3. The composite is the test-count-weighted mean of those per-compound indices.

A compound is published only with at least 5 tests carrying a numeric purity. No single compound may exceed 15% of the composite weight, so a heavily tested compound cannot dominate the headline figure. Blend vials and net-content-only tests are excluded from compound averages.

Why a minimum of five tests is required

Five tests is the floor below which a single outlier moves the average more than the underlying quality does. A compound with one or two results — Adipotide, IGF-1 DES, EPO (Erythropoietin) — renders an em dash rather than a number, because a two-test “average” is a data point, not a measurement.

What counts as an acceptable purity level

95% is the research-grade purity bar and 98% is a strong result. Across the published set, 0.32% of tests fall below 95%, so most tested material clears the research-grade threshold — see peptide purity standards for the reasoning behind those cut-offs.

How the index differs from a vendor's own COA

A vendor's certificate reports one batch the vendor selected and paid to test; the index aggregates third-party results across many vendors and batches, with no vendor input into which samples are included. Because Peptigrity sells nothing and takes no vendor payment, no seller can influence the number that represents their compound.

Which compounds have enough data to be indexed

61 compounds currently meet the 5-test threshold, out of 64 with any published test. The full list, with each compound's index and 90-day change, is in the index by compound table above.

What the index does not measure

The index measures HPLC purity only. It does not measure endotoxin load, heavy-metal content, sterility, or batch-to-batch variance, and it is not a guarantee of any future batch. A high index means the tested samples were pure, not that every vial from every vendor will be.

How often the index updates

The index updates continuously as new certificates are submitted and approved; this page is regenerated hourly, and a nightly snapshot locks each day's figure so a citation dated to a given day stays reproducible.

How to cite the index

Attribution is free. Cite the composite with its date and sample size, and link to this page:

The Peptigrity Purity Index, Peptigrity, 2026-07-25. Composite 99.49 across 9,016 third-party HPLC tests. https://peptigrity.com/purity-index